Concepts (348)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Longevity | 52 | 2026 | 173 | 12.830 |
Why?
|
| Aging | 36 | 2026 | 783 | 5.110 |
Why?
|
| Polymorphism, Single Nucleotide | 24 | 2024 | 863 | 4.880 |
Why?
|
| Genotype | 22 | 2025 | 800 | 2.440 |
Why?
|
| Aged, 80 and over | 53 | 2026 | 2853 | 2.360 |
Why?
|
| Japan | 48 | 2025 | 348 | 2.340 |
Why?
|
| Hypertension | 10 | 2026 | 835 | 1.870 |
Why?
|
| Forkhead Transcription Factors | 7 | 2022 | 78 | 1.860 |
Why?
|
| Life Expectancy | 8 | 2024 | 72 | 1.540 |
Why?
|
| Aged | 51 | 2026 | 8214 | 1.510 |
Why?
|
| Cognition | 10 | 2025 | 473 | 1.380 |
Why?
|
| Male | 87 | 2026 | 23409 | 1.350 |
Why?
|
| Alleles | 10 | 2024 | 352 | 1.330 |
Why?
|
| Humans | 111 | 2026 | 43102 | 1.230 |
Why?
|
| Coronary Artery Disease | 8 | 2024 | 163 | 1.180 |
Why?
|
| Coronary Disease | 7 | 2020 | 123 | 1.080 |
Why?
|
| Apolipoprotein E4 | 2 | 2025 | 67 | 1.070 |
Why?
|
| Prospective Studies | 20 | 2025 | 1600 | 1.020 |
Why?
|
| Risk Factors | 38 | 2025 | 3994 | 1.010 |
Why?
|
| Genetic Association Studies | 4 | 2021 | 118 | 1.000 |
Why?
|
| Mortality | 7 | 2024 | 175 | 0.990 |
Why?
|
| Hawaii | 23 | 2025 | 2011 | 0.920 |
Why?
|
| Phenotype | 7 | 2020 | 780 | 0.920 |
Why?
|
| Cognition Disorders | 4 | 2022 | 243 | 0.900 |
Why?
|
| Stroke | 4 | 2023 | 340 | 0.840 |
Why?
|
| Caloric Restriction | 5 | 2016 | 34 | 0.840 |
Why?
|
| Case-Control Studies | 9 | 2020 | 1285 | 0.770 |
Why?
|
| Apolipoprotein E2 | 1 | 2022 | 6 | 0.760 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 213 | 0.750 |
Why?
|
| Middle Aged | 43 | 2026 | 12222 | 0.730 |
Why?
|
| Genetic Variation | 5 | 2021 | 430 | 0.720 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 80 | 0.720 |
Why?
|
| Cardiovascular Diseases | 8 | 2026 | 749 | 0.700 |
Why?
|
| Longitudinal Studies | 12 | 2024 | 1063 | 0.680 |
Why?
|
| Proteomics | 1 | 2023 | 378 | 0.650 |
Why?
|
| Life Style | 9 | 2024 | 334 | 0.650 |
Why?
|
| Exercise | 3 | 2025 | 692 | 0.640 |
Why?
|
| Aortic Diseases | 4 | 2025 | 34 | 0.630 |
Why?
|
| Health Behavior | 2 | 2014 | 575 | 0.600 |
Why?
|
| Diet | 5 | 2022 | 826 | 0.590 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 423 | 0.570 |
Why?
|
| Population Dynamics | 2 | 2016 | 50 | 0.570 |
Why?
|
| Leukocytes | 1 | 2018 | 80 | 0.560 |
Why?
|
| Cohort Studies | 11 | 2026 | 1759 | 0.560 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 19 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2017 | 20 | 0.540 |
Why?
|
| Cause of Death | 4 | 2017 | 186 | 0.530 |
Why?
|
| Insulin | 3 | 2014 | 258 | 0.530 |
Why?
|
| Fatty Acids, Omega-3 | 5 | 2022 | 40 | 0.520 |
Why?
|
| Risk Assessment | 10 | 2025 | 863 | 0.520 |
Why?
|
| Blood Pressure | 3 | 2017 | 666 | 0.510 |
Why?
|
| Female | 39 | 2025 | 24698 | 0.500 |
Why?
|
| Signal Transduction | 2 | 2018 | 2157 | 0.490 |
Why?
|
| Gene Frequency | 5 | 2018 | 206 | 0.470 |
Why?
|
| Functional Food | 2 | 2014 | 5 | 0.430 |
Why?
|
| Body Height | 2 | 2014 | 53 | 0.430 |
Why?
|
| Antioxidants | 3 | 2023 | 443 | 0.430 |
Why?
|
| Overweight | 2 | 2014 | 249 | 0.430 |
Why?
|
| Body Mass Index | 11 | 2021 | 925 | 0.430 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2014 | 23 | 0.420 |
Why?
|
| United States | 19 | 2025 | 5205 | 0.410 |
Why?
|
| Forecasting | 1 | 2014 | 136 | 0.410 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2020 | 760 | 0.400 |
Why?
|
| Receptors, Somatotropin | 2 | 2024 | 18 | 0.390 |
Why?
|
| Climate Change | 1 | 2013 | 53 | 0.390 |
Why?
|
| Dementia, Vascular | 2 | 2023 | 35 | 0.390 |
Why?
|
| Age Factors | 9 | 2020 | 1154 | 0.380 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 201 | 0.370 |
Why?
|
| Follow-Up Studies | 10 | 2024 | 1067 | 0.370 |
Why?
|
| Open Reading Frames | 1 | 2012 | 79 | 0.360 |
Why?
|
| Haplotypes | 3 | 2018 | 197 | 0.360 |
Why?
|
| Carrier Proteins | 1 | 2014 | 321 | 0.360 |
Why?
|
| Health Status | 5 | 2014 | 442 | 0.360 |
Why?
|
| Alcohol Drinking | 4 | 2024 | 609 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2023 | 21 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 734 | 0.340 |
Why?
|
| Adult | 27 | 2025 | 13872 | 0.320 |
Why?
|
| Heat-Shock Proteins | 2 | 2023 | 57 | 0.320 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 2 | 2021 | 13 | 0.320 |
Why?
|
| Cross-Sectional Studies | 14 | 2024 | 3156 | 0.300 |
Why?
|
| Eicosapentaenoic Acid | 3 | 2022 | 14 | 0.300 |
Why?
|
| Docosahexaenoic Acids | 3 | 2022 | 19 | 0.300 |
Why?
|
| Morbidity | 2 | 2016 | 97 | 0.300 |
Why?
|
| Heterozygote | 3 | 2018 | 110 | 0.290 |
Why?
|
| Energy Intake | 2 | 2009 | 164 | 0.280 |
Why?
|
| Cardiovascular System | 1 | 2008 | 37 | 0.270 |
Why?
|
| Incidence | 10 | 2025 | 1078 | 0.260 |
Why?
|
| Logistic Models | 3 | 2025 | 1009 | 0.260 |
Why?
|
| Circumcision, Male | 2 | 2017 | 8 | 0.260 |
Why?
|
| Siblings | 1 | 2006 | 22 | 0.240 |
Why?
|
| Leisure Activities | 1 | 2025 | 41 | 0.230 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 1001 | 0.220 |
Why?
|
| Apolipoproteins E | 2 | 2022 | 138 | 0.220 |
Why?
|
| Health | 3 | 2009 | 30 | 0.220 |
Why?
|
| Anthropometry | 2 | 2017 | 97 | 0.210 |
Why?
|
| Animals | 10 | 2023 | 16992 | 0.210 |
Why?
|
| Curcuma | 2 | 2014 | 5 | 0.210 |
Why?
|
| Lipoproteins, HDL | 2 | 2018 | 48 | 0.210 |
Why?
|
| Asia | 2 | 2023 | 98 | 0.210 |
Why?
|
| Phenylbutyrates | 1 | 2023 | 5 | 0.210 |
Why?
|
| Flavonols | 1 | 2023 | 19 | 0.210 |
Why?
|
| Dietary Carbohydrates | 2 | 2016 | 34 | 0.210 |
Why?
|
| Nerve Regeneration | 1 | 2004 | 46 | 0.210 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 495 | 0.200 |
Why?
|
| Reference Values | 2 | 2014 | 211 | 0.200 |
Why?
|
| Genetics | 1 | 2023 | 10 | 0.200 |
Why?
|
| Financing, Personal | 1 | 2023 | 9 | 0.200 |
Why?
|
| Retirement | 1 | 2023 | 13 | 0.200 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 167 | 0.200 |
Why?
|
| Cholesterol | 4 | 2015 | 232 | 0.200 |
Why?
|
| Gene Expression | 2 | 2014 | 701 | 0.190 |
Why?
|
| Prevalence | 6 | 2020 | 1612 | 0.190 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 199 | 0.190 |
Why?
|
| Hydrogen Sulfide | 1 | 2023 | 77 | 0.190 |
Why?
|
| Republic of Korea | 6 | 2024 | 141 | 0.190 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 638 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 183 | 0.180 |
Why?
|
| Phospholipids | 1 | 2022 | 70 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 386 | 0.180 |
Why?
|
| Proportional Hazards Models | 5 | 2014 | 518 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 104 | 0.170 |
Why?
|
| Cholesterol, HDL | 3 | 2018 | 99 | 0.170 |
Why?
|
| Heart Diseases | 1 | 2022 | 112 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2025 | 245 | 0.170 |
Why?
|
| Survival Analysis | 3 | 2021 | 368 | 0.170 |
Why?
|
| Depression | 2 | 2024 | 863 | 0.170 |
Why?
|
| Obesity | 4 | 2018 | 1151 | 0.160 |
Why?
|
| Adiposity | 2 | 2018 | 157 | 0.160 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 162 | 0.160 |
Why?
|
| Activities of Daily Living | 4 | 2025 | 139 | 0.160 |
Why?
|
| Pediatrics | 2 | 2017 | 70 | 0.150 |
Why?
|
| Smoking | 6 | 2018 | 1024 | 0.150 |
Why?
|
| Chromatin | 2 | 2018 | 186 | 0.150 |
Why?
|
| Sirtuins | 1 | 2018 | 14 | 0.150 |
Why?
|
| Xanthophylls | 3 | 2023 | 21 | 0.140 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 86 | 0.140 |
Why?
|
| Australia | 3 | 2026 | 103 | 0.140 |
Why?
|
| Abdominal Fat | 1 | 2018 | 21 | 0.140 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 29 | 0.140 |
Why?
|
| Hydra | 1 | 2018 | 4 | 0.140 |
Why?
|
| Leukocyte Count | 2 | 2015 | 69 | 0.140 |
Why?
|
| Fasting | 3 | 2014 | 56 | 0.140 |
Why?
|
| Sarcopenia | 1 | 2017 | 15 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 455 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 269 | 0.130 |
Why?
|
| Nutritional Status | 2 | 2016 | 119 | 0.130 |
Why?
|
| Laminin | 1 | 2017 | 58 | 0.130 |
Why?
|
| Population | 1 | 2016 | 8 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 515 | 0.130 |
Why?
|
| Neurons | 1 | 2004 | 1263 | 0.130 |
Why?
|
| Seafood | 2 | 2014 | 26 | 0.130 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 54 | 0.130 |
Why?
|
| Genome, Human | 1 | 2017 | 144 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 91 | 0.120 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 6 | 0.120 |
Why?
|
| Dietary Proteins | 1 | 2016 | 35 | 0.120 |
Why?
|
| Quality of Life | 2 | 2014 | 616 | 0.120 |
Why?
|
| Brain | 2 | 2023 | 1472 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2026 | 539 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 291 | 0.120 |
Why?
|
| Binding Sites | 1 | 2017 | 671 | 0.120 |
Why?
|
| Base Sequence | 1 | 2017 | 983 | 0.110 |
Why?
|
| Vegetables | 2 | 2014 | 147 | 0.110 |
Why?
|
| Calcinosis | 2 | 2013 | 62 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 107 | 0.110 |
Why?
|
| Granulocytes | 1 | 2014 | 26 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2023 | 187 | 0.110 |
Why?
|
| Blood Glucose | 2 | 2021 | 389 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2016 | 263 | 0.110 |
Why?
|
| Drinking Behavior | 1 | 2014 | 18 | 0.110 |
Why?
|
| Glycemic Index | 2 | 2011 | 10 | 0.110 |
Why?
|
| Fish Products | 1 | 2014 | 2 | 0.110 |
Why?
|
| Survival Rate | 3 | 2016 | 355 | 0.110 |
Why?
|
| Cucurbitaceae | 1 | 2014 | 6 | 0.110 |
Why?
|
| Tea | 1 | 2014 | 46 | 0.100 |
Why?
|
| Ipomoea batatas | 1 | 2014 | 8 | 0.100 |
Why?
|
| Spices | 1 | 2014 | 9 | 0.100 |
Why?
|
| Nutritional Sciences | 1 | 2014 | 25 | 0.100 |
Why?
|
| Seaweed | 1 | 2014 | 14 | 0.100 |
Why?
|
| Water Pollution | 1 | 2013 | 13 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 384 | 0.100 |
Why?
|
| Neutrophils | 1 | 2014 | 145 | 0.100 |
Why?
|
| Protein Binding | 1 | 2017 | 1082 | 0.100 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 64 | 0.100 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 76 | 0.100 |
Why?
|
| Diet, Mediterranean | 1 | 2014 | 37 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2013 | 5 | 0.100 |
Why?
|
| Genes, jun | 1 | 2013 | 7 | 0.100 |
Why?
|
| Genes, p16 | 1 | 2013 | 11 | 0.100 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2013 | 6 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2017 | 561 | 0.100 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 22 | 0.100 |
Why?
|
| Soy Foods | 1 | 2014 | 60 | 0.100 |
Why?
|
| Arteries | 1 | 2014 | 81 | 0.100 |
Why?
|
| Exodeoxyribonucleases | 1 | 2013 | 17 | 0.100 |
Why?
|
| Geriatrics | 1 | 2014 | 67 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2014 | 117 | 0.100 |
Why?
|
| Hand Strength | 2 | 2011 | 40 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2014 | 549 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 81 | 0.100 |
Why?
|
| Air Pollution | 1 | 2013 | 87 | 0.100 |
Why?
|
| Fruit | 1 | 2014 | 178 | 0.090 |
Why?
|
| Dementia | 1 | 2014 | 160 | 0.090 |
Why?
|
| Disease Progression | 3 | 2025 | 667 | 0.090 |
Why?
|
| Canada | 3 | 2017 | 163 | 0.090 |
Why?
|
| Time Factors | 5 | 2016 | 1857 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2011 | 63 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 286 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2013 | 201 | 0.090 |
Why?
|
| Sweden | 2 | 2024 | 18 | 0.080 |
Why?
|
| France | 2 | 2024 | 23 | 0.080 |
Why?
|
| Spain | 2 | 2024 | 44 | 0.080 |
Why?
|
| Motor Activity | 2 | 2011 | 437 | 0.080 |
Why?
|
| Cholesterol, LDL | 2 | 2008 | 73 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 440 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 611 | 0.080 |
Why?
|
| Educational Status | 2 | 2023 | 339 | 0.080 |
Why?
|
| Carcinoma | 1 | 2011 | 108 | 0.080 |
Why?
|
| Micronutrients | 1 | 2010 | 45 | 0.080 |
Why?
|
| Pennsylvania | 3 | 2017 | 43 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2014 | 469 | 0.080 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Prognosis | 4 | 2015 | 861 | 0.070 |
Why?
|
| Postmenopause | 1 | 2009 | 141 | 0.070 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2008 | 5 | 0.070 |
Why?
|
| Triglycerides | 2 | 2009 | 147 | 0.070 |
Why?
|
| Aortography | 2 | 2019 | 10 | 0.070 |
Why?
|
| Diet Surveys | 2 | 2009 | 99 | 0.070 |
Why?
|
| Carotid Stenosis | 1 | 2008 | 16 | 0.070 |
Why?
|
| Inflammation | 1 | 2014 | 758 | 0.070 |
Why?
|
| Free Radicals | 1 | 2008 | 70 | 0.070 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 37 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 218 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 74 | 0.070 |
Why?
|
| Carotenoids | 1 | 2008 | 74 | 0.070 |
Why?
|
| Haplorhini | 1 | 2007 | 23 | 0.070 |
Why?
|
| Lipid Peroxidation | 1 | 2008 | 140 | 0.070 |
Why?
|
| Textile Industry | 1 | 2007 | 2 | 0.070 |
Why?
|
| Efficiency | 1 | 2007 | 14 | 0.070 |
Why?
|
| Young Adult | 1 | 2018 | 5080 | 0.070 |
Why?
|
| Lipids | 1 | 2009 | 256 | 0.070 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 66 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 415 | 0.060 |
Why?
|
| Confidence Intervals | 3 | 2014 | 162 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 82 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 1234 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2006 | 90 | 0.060 |
Why?
|
| Pedigree | 1 | 2006 | 94 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2009 | 302 | 0.060 |
Why?
|
| Research Design | 1 | 2008 | 385 | 0.060 |
Why?
|
| Physical Fitness | 1 | 2006 | 90 | 0.060 |
Why?
|
| Ankle Brachial Index | 2 | 2016 | 11 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2009 | 1003 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 512 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2006 | 187 | 0.060 |
Why?
|
| Neoplasms | 2 | 2014 | 1377 | 0.060 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 159 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2005 | 70 | 0.060 |
Why?
|
| Switzerland | 1 | 2024 | 2 | 0.060 |
Why?
|
| Eating | 1 | 2006 | 167 | 0.060 |
Why?
|
| Hong Kong | 1 | 2024 | 29 | 0.060 |
Why?
|
| GAP-43 Protein | 1 | 2004 | 9 | 0.050 |
Why?
|
| Neurofilament Proteins | 1 | 2004 | 30 | 0.050 |
Why?
|
| China | 2 | 2016 | 229 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 259 | 0.050 |
Why?
|
| Meclizine | 1 | 2023 | 2 | 0.050 |
Why?
|
| Ganglia, Spinal | 1 | 2004 | 42 | 0.050 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 258 | 0.050 |
Why?
|
| Tubulin | 1 | 2004 | 96 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2023 | 16 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2017 | 972 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2023 | 63 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2022 | 134 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1092 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2021 | 139 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 94 | 0.040 |
Why?
|
| Sex Factors | 2 | 2014 | 1028 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2022 | 213 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 284 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1271 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1766 | 0.040 |
Why?
|
| International Cooperation | 1 | 2018 | 52 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2024 | 518 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1723 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 46 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 173 | 0.030 |
Why?
|
| Physical Examination | 2 | 2008 | 45 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 6644 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2011 | 587 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 149 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 90 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 197 | 0.030 |
Why?
|
| Environment | 1 | 2018 | 149 | 0.030 |
Why?
|
| Systole | 1 | 2017 | 67 | 0.030 |
Why?
|
| Diastole | 1 | 2017 | 47 | 0.030 |
Why?
|
| Body Composition | 1 | 2017 | 159 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2016 | 18 | 0.030 |
Why?
|
| Rats | 1 | 2004 | 3735 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2007 | 490 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 77 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 151 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2016 | 2544 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 316 | 0.030 |
Why?
|
| Plethysmography | 1 | 2014 | 6 | 0.030 |
Why?
|
| Manometry | 1 | 2014 | 8 | 0.030 |
Why?
|
| Vitamin D | 1 | 2016 | 196 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2014 | 12 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2014 | 27 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 107 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 341 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2014 | 36 | 0.030 |
Why?
|
| Aorta | 1 | 2014 | 198 | 0.020 |
Why?
|
| Iceland | 1 | 2012 | 5 | 0.020 |
Why?
|
| Goals | 1 | 2012 | 34 | 0.020 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2011 | 5 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2011 | 34 | 0.020 |
Why?
|
| Thinness | 1 | 2010 | 32 | 0.020 |
Why?
|
| gamma-Tocopherol | 1 | 2010 | 19 | 0.020 |
Why?
|
| Homocysteine | 1 | 2010 | 21 | 0.020 |
Why?
|
| Oregon | 1 | 2010 | 64 | 0.020 |
Why?
|
| alpha-Tocopherol | 1 | 2010 | 27 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2010 | 23 | 0.020 |
Why?
|
| Folic Acid | 1 | 2010 | 49 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 111 | 0.020 |
Why?
|
| Sodium | 1 | 2010 | 102 | 0.020 |
Why?
|
| Potassium | 1 | 2010 | 109 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 375 | 0.020 |
Why?
|
| Tunica Media | 1 | 2008 | 15 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2008 | 22 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 224 | 0.020 |
Why?
|
| Radiography | 1 | 2007 | 71 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 249 | 0.020 |
Why?
|
| Psychology, Social | 1 | 2007 | 5 | 0.020 |
Why?
|
| Art | 1 | 2007 | 3 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 760 | 0.020 |
Why?
|
| Cuba | 1 | 2006 | 33 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2011 | 449 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2006 | 22 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 47 | 0.020 |
Why?
|
| Culture | 1 | 2007 | 172 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 575 | 0.020 |
Why?
|
| Exercise Test | 1 | 2006 | 74 | 0.010 |
Why?
|
| Postural Balance | 1 | 2006 | 37 | 0.010 |
Why?
|
| Walking | 1 | 2006 | 88 | 0.010 |
Why?
|
| Registries | 1 | 2007 | 437 | 0.010 |
Why?
|
| Bronchopneumonia | 1 | 2004 | 2 | 0.010 |
Why?
|
| Autopsy | 1 | 2004 | 48 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 1081 | 0.010 |
Why?
|